{"id":"https://openalex.org/A5110137685","orcid":null,"observed_orcids":[],"display_name":"Takafumi Ohmura","raw_author_names":["Takafumi OHMURA","Takafumi Ohmura"],"full_name":"Takafumi OHMURA","works_count":18,"cited_by_count":553,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":12,"i10_index":13},"ids":{"openalex":"https://openalex.org/A5110137685","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210122547","ror":"https://ror.org/02vgs9327","display_name":"Kumamoto University Hospital","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210122547"]},"years":[2014,2012,2007,2002,2001]},{"institution":{"id":"https://openalex.org/I4405286258","ror":"https://ror.org/01mrmn149","display_name":"Institute of Molecular Embryology and Genetics, Kumamoto University","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405286258","https://openalex.org/I96036126"]},"years":[1999]},{"institution":{"id":"https://openalex.org/I96036126","ror":"https://ror.org/02cgss904","display_name":"Kumamoto University","country_code":"JP","type":"education","lineage":["https://openalex.org/I96036126"]},"years":[2005,2003,1999,1990,1986,1985]}],"last_known_institutions":[{"id":"https://openalex.org/I4210122547","ror":"https://ror.org/02vgs9327","display_name":"Kumamoto University Hospital","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210122547"]}],"topics":[{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","count":7,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12620","display_name":"Signaling Pathways in Disease","count":4,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","count":3,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","count":3,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","count":3,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12620","display_name":"Signaling Pathways in Disease","value":5.83e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","value":2.27e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","value":1.47e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","value":1.33e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11591","display_name":"NF-\u03baB Signaling Pathways","value":1.17e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9279285669326782},{"id":"153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","score":0.807198166847229},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.7339348196983337},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.6724238991737366},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.29339343309402466}],"counts_by_year":[{"year":1985,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":1986,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":1990,"works_count":3,"oa_works_count":0,"cited_by_count":0},{"year":1999,"works_count":2,"oa_works_count":1,"cited_by_count":0},{"year":2001,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2002,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2003,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":2005,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2007,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2012,"works_count":1,"oa_works_count":0,"cited_by_count":20},{"year":2013,"works_count":1,"oa_works_count":0,"cited_by_count":17},{"year":2014,"works_count":1,"oa_works_count":0,"cited_by_count":25},{"year":2015,"works_count":0,"oa_works_count":0,"cited_by_count":22},{"year":2016,"works_count":0,"oa_works_count":0,"cited_by_count":16},{"year":2017,"works_count":0,"oa_works_count":0,"cited_by_count":17},{"year":2018,"works_count":0,"oa_works_count":0,"cited_by_count":16},{"year":2019,"works_count":0,"oa_works_count":0,"cited_by_count":17},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":20},{"year":2021,"works_count":0,"oa_works_count":0,"cited_by_count":25},{"year":2022,"works_count":0,"oa_works_count":0,"cited_by_count":20},{"year":2023,"works_count":0,"oa_works_count":0,"cited_by_count":21},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":6},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":11},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":12}],"display_name_alternatives":["Takafumi OHMURA","Takafumi Ohmura"],"block_key":"t ohmura","works_api_url":"https://api.openalex.org/works?filter=author.id:A5110137685","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5110137685","updated_date":"2026-11-21T13:19:37","created_date":"2016-06-24T00:00:00"}
